01
Overview
𧫠Translocation Risk: Sub-100nm plastic particles permeate intestinal epithelium into systemic circulation at 84% capture rate.
Bacterial Trapping
Probiotic strain Lactobacillus aggregates nanoparticles into non-absorbable complexes.
02
Microplastic Neutralization (Before β Now)
ΠΡΠ»ΠΎ: Passive systemic bioaccumulation across organs without therapeutic recourse β Π‘ΡΠ°Π»ΠΎ: Active electrostatic binding and clearance of up to 84% nanoparticles
ΠΡΠ»ΠΎ: Chronic mucosal inflammation driven by microscopic plastic shards β Π‘ΡΠ°Π»ΠΎ: Epithelial restoration mediated by probiotic anti-inflammatory metabolites
03
Overview
Clearance Rate: Up to 84% nanoparticles
Strain: Lactobacillus fermentum
Particle Size: < 100 nm
Safety Status: GRAS approved
30 seconds
Key facts
Engineered probiotic strains displaying surface exopolysaccharides capture up to 84% of ingested polystyrene nanoparticles below 100 nm.
- Engineered probiotic strains displaying surface exopolysaccharides capture up to 84% of ingested polystyrene nanoparticles below 100 nm.
Want to go deeper?
The Hook & Core Paradox
Living Magnet for Polymers: Can engineered gut microbes cleanse our tissues of perpetual plastic debris?
Between the Lines (Market & Margin Shift)
Functional nutrition paradigm: preventive toxicology transitions from synthetic binders to daily probiotic cultures.
The Bottleneck (Physical & Engineering Barrier)
Gastric acid survival barrier: sustaining cell viability without denaturing molecular electrostatic traps.
3β5 Year Horizon (Structural Shift)
Microbiome shield: engineered homeostatic stabilization of the human gut amidst global plastic pollution.
Chronicle: Past 5 Years
2024β2025
Initial research phase and prototype validation.
2026
Production deployment and commercial integration.
Forecast Scenarios
3 Years
Ecosystem consolidation and protocol standardization.
5 Years
Ubiquitous deployment across operational platforms.
10 Years
Foundation for next-generation autonomous systems.